EUVIMEDEUVIMED entdecken
EditorialOpen Access · CC BY 4.0

Special Issue on the Promise of Psychedelic Pharmacology in Neuropsychiatric Drug Development

Andreas Halman iD, Ross Corriden

Pharmacology Research & Perspectives · 2026-08 · 14 (4)

DOI: 10.1002/prp2.70309 ↗

Kurz gefasst

Editorial in der Zeitschrift Pharmacology Research & Perspectives, online erschienen am 29.07.2026. Verfasst von Andreas Halman und 1 weiteren Autor:innen. Beteiligte Einrichtung: Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. Die Arbeit nennt 6 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
  • Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Victoria, Australia.
  • Cancer Therapies, Stem Cell Medicine, Murdoch Children's Research Institute, Parkville, Victoria, Australia.
  • Pharmacology Research & Perspectives Editorial Board, New Castle, New South Wales, Australia.

ORCID-Profile: Andreas Halman

Zitieren

APA

Halman, A., & Corriden, R. (2026). Special Issue on the Promise of Psychedelic Pharmacology in Neuropsychiatric Drug Development. Pharmacology Research & Perspectives, 14(4). https://doi.org/10.1002/prp2.70309

Vancouver

Halman A, Corriden R. Special Issue on the Promise of Psychedelic Pharmacology in Neuropsychiatric Drug Development. Pharmacology Research & Perspectives. 2026;14(4). doi:10.1002/prp2.70309

BibTeX
@article{Halman2026,
  author = {Halman, Andreas and Corriden, Ross},
  title = {Special Issue on the Promise of Psychedelic Pharmacology in Neuropsychiatric Drug Development},
  journal = {Pharmacology Research & Perspectives},
  year = {2026},
  volume = {14},
  number = {4},
  doi = {10.1002/prp2.70309}
}
Kostenlos starten →